elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q62063038-E2656598-36B7-4983-B75B-1E079A0DE77C
Q62063038-E2656598-36B7-4983-B75B-1E079A0DE77C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q62063038-E2656598-36B7-4983-B75B-1E079A0DE77C
Rituximab, Idelalisib, and Venetoclax in Relapsed/Refractory CLL
P4844
Q62063038-E2656598-36B7-4983-B75B-1E079A0DE77C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q62063038-E2656598-36B7-4983-B75B-1E079A0DE77C
rank
NormalRank
type
BestRank
Statement
P4844
venetoclax